908 Devices (MASS) Stock Price

908 Devices Price

NASDAQ·CLOSED
8.88USD+0.58 (+6.75 %)
Market closed

Revenue has compounded at 15.2% per year over the past 7 years to 56.20 M USD. 908 Devices's net margin stands at -65.2%, down from -53.8% several years earlier. Analysts set a median price target of 10.20 USD, implying 14.9% above the current price. Of 10 analysts, 9 rate the stock a buy — an overall Buy consensus. The stock trades about 74% above its 52-week low.

908 Devices stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of 908 Devices over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how 908 Devices stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing 908 Devices's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

908 Devices Stock Price History
Date908 Devices Price
8/7/20268.88 USD
8/6/20268.30 USD
8/5/20268.49 USD
8/4/20268.56 USD
8/3/20268.42 USD
7/31/20268.01 USD
7/30/20267.64 USD
7/29/20267.62 USD
7/27/20267.05 USD
7/23/20267.11 USD
7/22/20267.24 USD
7/21/20267.35 USD
7/20/20267.03 USD
7/17/20267.35 USD
7/16/20267.41 USD
7/15/20268.05 USD
7/14/20268.16 USD
7/13/20267.98 USD
7/10/20268.10 USD
7/9/20268.13 USD
7/8/20267.70 USD
7/7/20268.07 USD
7/6/20268.68 USD
7/2/20268.69 USD
7/1/20268.88 USD
6/30/20268.70 USD
6/29/20268.81 USD
6/26/20268.78 USD
6/25/20268.98 USD
6/24/20268.97 USD
6/23/20268.73 USD
6/22/20268.62 USD
6/18/20268.85 USD
6/17/20268.58 USD
6/16/20268.64 USD
6/15/20268.62 USD
6/12/20268.27 USD
6/11/20268.22 USD
6/10/20268.16 USD
6/9/20267.99 USD
6/8/20268.10 USD
6/5/20267.93 USD
6/4/20268.82 USD
6/3/20268.66 USD
6/2/20268.85 USD
6/1/20268.63 USD
5/29/20268.41 USD
5/28/20268.93 USD
5/27/20268.16 USD
5/26/20267.92 USD
5/22/20267.28 USD
5/21/20267.12 USD
5/20/20266.98 USD
5/19/20266.78 USD
5/18/20266.64 USD
5/15/20266.90 USD
5/14/20267.64 USD
5/13/20267.54 USD
5/12/20267.65 USD
5/11/20267.93 USD
5/8/20268.17 USD
5/7/20268.08 USD
5/6/20268.06 USD
5/5/20267.09 USD
5/4/20266.55 USD
5/1/20266.81 USD
4/30/20266.83 USD
4/29/20266.50 USD
4/28/20266.74 USD
4/27/20266.74 USD
4/24/20266.74 USD
4/22/20267.13 USD
4/21/20267.26 USD
4/20/20267.30 USD
4/17/20267.16 USD
4/16/20267.42 USD
4/15/20267.37 USD
4/14/20267.32 USD
4/13/20267.20 USD
4/10/20267.14 USD
4/9/20266.96 USD
4/8/20267.03 USD
4/7/20266.76 USD
4/6/20266.85 USD
4/5/20266.85 USD
4/2/20266.61 USD
4/1/20266.61 USD
3/31/20266.21 USD
3/30/20266.12 USD
3/29/20265.75 USD
3/27/20265.78 USD
3/26/20265.78 USD
3/25/20266.14 USD
3/24/20266.32 USD
3/23/20266.27 USD
3/22/20266.11 USD
3/20/20266.11 USD
3/19/20266.11 USD
3/18/20266.09 USD
3/17/20265.99 USD
3/16/20266.22 USD
3/15/20266.09 USD
3/13/20266.07 USD
3/12/20266.07 USD
3/11/20266.01 USD
3/10/20266.26 USD
3/9/20266.26 USD
3/8/20266.37 USD
3/6/20266.26 USD
3/5/20266.26 USD
3/4/20266.75 USD
3/3/20266.74 USD
3/2/20266.32 USD
3/1/20266.61 USD
2/27/20266.90 USD
2/26/20266.90 USD
2/25/20266.96 USD
2/24/20266.82 USD
2/23/20266.79 USD
2/22/20266.49 USD
2/20/20266.67 USD
2/19/20266.67 USD
2/18/20266.99 USD
2/17/20266.88 USD
2/16/20266.76 USD
2/13/20266.49 USD
2/12/20266.49 USD
2/11/20266.41 USD
2/10/20266.60 USD
2/9/20266.77 USD
2/8/20266.89 USD
2/6/20266.55 USD
2/5/20266.55 USD
2/4/20266.20 USD
2/3/20266.33 USD
2/2/20266.44 USD
2/1/20266.19 USD
1/30/20266.31 USD
1/29/20266.31 USD
1/28/20266.35 USD
1/27/20266.56 USD
1/26/20266.83 USD
1/25/20266.64 USD
1/23/20266.84 USD
1/22/20266.84 USD
1/21/20267.00 USD
1/20/20266.73 USD
1/19/20266.52 USD
1/16/20265.47 USD
1/15/20265.47 USD
1/14/20265.52 USD
1/13/20265.44 USD
1/12/20265.37 USD
1/11/20265.48 USD
1/9/20265.40 USD
1/8/20265.40 USD
1/7/20265.42 USD
1/6/20265.45 USD
1/5/20265.40 USD
1/4/20265.48 USD
1/2/20265.09 USD
1/1/20265.09 USD
12/31/20255.25 USD
12/30/20255.25 USD
12/29/20255.21 USD
12/28/20255.33 USD
12/26/20255.41 USD
12/25/20255.41 USD
12/24/20255.45 USD
12/23/20255.45 USD
12/22/20255.41 USD
12/21/20255.93 USD
12/19/20255.84 USD
12/18/20255.84 USD
12/17/20255.43 USD
12/16/20255.66 USD
12/15/20255.78 USD
12/14/20255.91 USD
12/12/20255.98 USD
12/11/20255.98 USD
12/10/20256.40 USD
12/9/20256.58 USD
12/8/20256.56 USD
12/7/20256.68 USD
12/5/20256.57 USD
12/4/20256.57 USD
12/3/20256.65 USD
12/2/20256.22 USD
12/1/20256.09 USD
11/30/20256.14 USD
11/28/20256.35 USD
11/27/20256.35 USD
11/26/20256.41 USD
11/25/20256.41 USD
11/24/20256.46 USD
11/23/20256.18 USD
11/21/20255.91 USD
11/20/20255.91 USD
11/19/20255.70 USD
11/18/20255.60 USD
11/17/20255.35 USD
11/16/20255.38 USD
11/14/20255.48 USD
11/13/20255.48 USD
11/12/20255.81 USD
11/11/20255.90 USD
11/10/20255.90 USD
11/9/20256.40 USD
11/7/20257.38 USD
11/6/20257.38 USD
11/5/20257.80 USD
11/4/20258.10 USD
11/3/20257.75 USD
11/2/20257.93 USD
10/31/20257.98 USD
10/30/20257.98 USD
10/29/20257.63 USD
10/28/20257.69 USD
10/27/20257.99 USD
10/26/20258.33 USD
10/23/20258.51 USD
10/22/20258.40 USD
10/21/20258.30 USD
10/20/20258.77 USD
10/19/20258.99 USD
10/16/20258.56 USD
10/15/20258.68 USD
10/14/20258.60 USD
10/13/20258.19 USD
10/12/20257.87 USD
10/9/20258.00 USD
10/8/20258.80 USD
10/7/20259.15 USD
10/6/20258.91 USD
10/5/20258.76 USD
10/2/20259.07 USD
10/1/20258.75 USD
9/30/20258.99 USD
9/29/20258.76 USD
9/28/20258.15 USD
9/25/20258.01 USD
9/24/20258.22 USD
9/23/20257.56 USD
9/22/20257.55 USD
9/21/20257.55 USD
9/18/20257.30 USD
9/17/20256.82 USD
9/16/20256.53 USD
9/15/20256.16 USD
9/14/20256.02 USD
9/11/20255.60 USD
9/10/20255.72 USD
9/9/20255.70 USD
9/8/20255.65 USD
9/7/20255.64 USD
9/4/20255.44 USD
9/3/20255.50 USD
9/2/20255.52 USD
9/1/20255.94 USD
8/28/20256.25 USD
8/27/20256.26 USD
8/26/20256.30 USD
8/25/20256.37 USD
8/24/20256.27 USD
8/21/20256.45 USD
8/20/20256.02 USD
8/19/20255.98 USD
8/18/20256.20 USD
8/17/20256.27 USD
8/14/20256.63 USD
8/13/20257.07 USD
8/12/20257.05 USD
8/11/20256.47 USD
8/10/20256.43 USD
Access this data via the Eulerpool API

908 Devices Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
46.72 M USD
-35.38 M USD
-31.74 M USD
Jan 1, 2023
49.97 M USD
-42.76 M USD
-36.40 M USD
Jan 1, 2024
59.63 M USD
-76.72 M USD
-72.21 M USD
Jan 1, 2025
56.20 M USD
-24.18 M USD
-36.64 M USD
Jan 1, 2026 (e)
68.53 M USD
-47.76 M USD
-14.48 M USD
Jan 1, 2027 (e)
82.49 M USD
-57.49 M USD
-11.22 M USD
Jan 1, 2028 (e)
100.37 M USD
-69.94 M USD
-8.69 M USD
Jan 1, 2029 (e)
101.80 M USD
-70.94 M USD
-7.24 M USD

908 Devices Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 5:25 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
201820192020202120222023202420252026e2027e2028e2029e
22.0017.0026.0042.0046.0050.0059.0056.0068.0082.00100.00101.00
-22.7352.9461.549.528.7018.00-5.0821.4320.5921.951.00
54.5547.0653.8554.7656.5250.0049.1546.4346.4346.4346.4346.43
12.008.0014.0023.0026.0025.0029.0026.0031.5738.0746.4346.89
-6.00-12.00-5.00-21.00-35.00-42.00-76.00-24.00-47.00-57.00-69.00-70.00
-27.27-70.59-19.23-50.00-76.09-84.00-128.81-42.86-69.12-69.51-69.00-69.31
-7.00-13.00-12.00-22.00-31.00-36.00-72.00-36.00-14.00-11.00-8.00-7.00
85.71-7.6983.3340.9116.13100.00-50.00-61.11-21.43-27.27-12.50
38.926.9423.4929.4831.7532.4434.6738.9238.9238.9238.9238.92
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales 908 Devices generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue 908 Devices retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare 908 Devices's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares 908 Devices has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against 908 Devices's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

908 Devices stock margins

The 908 Devices margin analysis displays the gross margin, EBIT margin, as well as the profit margin of 908 Devices. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for 908 Devices.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
56.43 %
-52.66 %
-53.84 %
Jan 1, 2022
55.70 %
-75.73 %
-67.94 %
Jan 1, 2023
50.68 %
-85.57 %
-72.85 %
Jan 1, 2024
50.18 %
-128.65 %
-121.09 %
Jan 1, 2025
47.68 %
-43.03 %
-65.20 %
Jan 1, 2026 (e)
47.68 %
-69.68 %
-21.12 %
Jan 1, 2027 (e)
47.68 %
-69.68 %
-13.60 %
Jan 1, 2028 (e)
47.68 %
-69.68 %
-8.65 %

908 Devices Stock Revenue, EBIT, Earnings per Share

The 908 Devices earnings per share therefore indicates how much revenue 908 Devices has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
1.40 USD
-0.74 USD
-0.75 USD
Jan 1, 2022
1.47 USD
-1.11 USD
-1.00 USD
Jan 1, 2023
1.54 USD
-1.32 USD
-1.12 USD
Jan 1, 2024
1.72 USD
-2.21 USD
-2.08 USD
Jan 1, 2025
1.44 USD
-0.62 USD
-0.94 USD
Jan 1, 2026 (e)
1.89 USD
-1.23 USD
-0.40 USD
Jan 1, 2027 (e)
2.28 USD
-1.48 USD
-0.31 USD
Jan 1, 2028 (e)
2.77 USD
-1.80 USD
-0.24 USD

908 Devices business model & stock analysis

The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth.

908 Devices SWOT Analysis

Strengths

1. Innovative Technology: 908 Devices Inc. is known for its cutting-edge technology in chemical analysis and detection, which sets it apart from competitors.

2. Diverse Product Portfolio: The company offers a wide range of products catering to various industries, including safety and security, life sciences, and government agencies.

3. Strong Intellectual Property: 908 Devices Inc. holds several patents and has a strong intellectual property portfolio, providing a significant competitive advantage.

Weaknesses

1. Limited Market Penetration: Despite its innovative products, 908 Devices Inc. faces challenges in penetrating and capturing a larger market share due to intense competition.

2. Reliance on External Funding: The company heavily relies on external funding to support research and development activities, which may pose financial risks.

3. Geographical Limitations: 908 Devices Inc. is currently concentrated in North America, limiting its reach to other potential markets globally.

Opportunities

1. Growing Demand for Safety and Security: With increasing concerns regarding safety and security, there is a growing market opportunity for 908 Devices Inc.'s products in sectors such as law enforcement and defense.

2. Expansion into New Markets: By expanding its geographic presence and targeting untapped markets, the company can broaden its customer base and increase revenue.

3. Technological Advancements: The continuous advancement of technology provides an opportunity for 908 Devices Inc. to further enhance its existing products or develop new innovative solutions.

Threats

1. Intense Competition: The industry in which 908 Devices Inc. operates is highly competitive, with established players and new entrants constantly vying for market share.

2. Regulatory Challenges: Compliance with stringent regulations and obtaining necessary certifications can be a hindrance for the company's growth and expansion into new markets.

3. Economic Uncertainty: Fluctuations in the global economy can impact customer spending patterns, potentially leading to reduced demand for 908 Device Inc.'s products.

908 Devices Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

908 Devices Employees
Details
Date
908 Devices Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

908 Devices Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

908 Devices historical P/E ratio, EBIT multiple, and P/S ratio

908 Devices annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

908 Devices shares outstanding

The number of shares of 908 Devices was 38.92 M in 2025. This indicates how many shares 908 Devices is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
29.48 M Stocks
Jan 1, 2022
31.75 M Stocks
Jan 1, 2023
32.44 M Stocks
Jan 1, 2024
34.67 M Stocks
Jan 1, 2025
38.92 M Stocks
Jan 1, 2026 (e)
38.92 M Stocks
Jan 1, 2027 (e)
38.92 M Stocks
Jan 1, 2028 (e)
38.92 M Stocks

Current 908 Devices forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
90.00 % (9)
Hold
10.00 % (1)
Sell
0.00 % (0)
12M Price Target
10.20
Last Price
8.88
Currency
USD
12M Return Potential
14.86 %
LTM Return
0 %

908 Devices Analyst Rating Actions

DateFirmActionRatingReliability
8/5/2025
Leerink Partners
Leerink Partners
UpgradeMarket PerformOutperform
1/15/2025
Stephens & Co.
Stephens & Co.
MaintainedOverweight
11/13/2024
Stifel
Stifel
MaintainedBuy
11/13/2024
Leerink Partners
Leerink Partners
DowngradeOutperformMarket Perform
10/17/2024
Leerink Partners
Leerink Partners
MaintainedOutperform
5/13/2024
Stephens & Co.
Stephens & Co.
MaintainedOverweight
9/25/2023
Stephens & Co.
Stephens & Co.
MaintainedOverweight
2/7/2023
Stephens & Co.
Stephens & Co.
MaintainedOverweight
1/6/2023
SVB Leerink
SVB Leerink
MaintainedOutperform
11/15/2022
SVB Leerink
SVB Leerink
MaintainedOutperform

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

908 Devices Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/11/2026-0.17USD-15.68 MUSD-2026 Q2
5/12/2026-0.16USD-13.41 MUSD-2026 Q1
3/10/2026-0.07USD-16.16 MUSD-2025 Q4
11/12/2024-0.29USD-18.70 MUSD-2024 Q3
5/7/2024-0.34USD-10.27 MUSD-2024 Q1
3/5/2024-0.27USD-14.44 MUSD-2023 Q4
11/13/2023-0.23USD-16.16 MUSD-2023 Q3
8/7/2023-0.31USD-15.20 MUSD-2023 Q2
11/14/2022-0.22USD-15.92 MUSD-2022 Q3

EESG©

Eulerpool ESG Scorecard© for the 908 Devices stock

49/100
18
Environment
76
Social
53
Governance
E

Environment

20
Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees32
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

908 Devices shareholder structure

% Name
14.36840%
AWM Investment Company, Inc.
AWM Investment Company, Inc.
7.31771%
ARK Investment Management LLC
ARK Investment Management LLC
6.31980%
State Street Investment Management (US)
State Street Investment Management (US)
4.46753%
BlackRock Institutional Trust Company, N.A.
BlackRock Institutional Trust Company, N.A.
3.95445%
The Vanguard Group, Inc.
The Vanguard Group, Inc.
3.21993%
GM Advisory Group, LLC
GM Advisory Group, LLC
...

908 Devices Beneficial Ownership Filings (SEC 13D/G)

Free Float
75.0%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
21.10%
Robert Nelsen
Robert Nelsen
SEC ↗
21.10%
Crandell
Crandell
SEC ↗
21.10%
Clinton Bybee
Clinton Bybee
SEC ↗
16.48%
First Light Asset Management, LLC
First Light Asset Management, LLC
SEC ↗
15.10%
ARCH Venture Fund VII, L.P.
ARCH Venture Fund VII, L.P.
SEC ↗
14.70%
AWM Investment Company, Inc.
AWM Investment Company, Inc.
SEC ↗
12.00%
2.
2.
SEC ↗
7.00%
Robin C. John
Robin C. John
SEC ↗
7.00%
Finny Kuruvilla, M.D. Ph. D.
Finny Kuruvilla, M.D. Ph. D.
SEC ↗
7.00%
Eventide Asset Management, LLC
Eventide Asset Management, LLC
SEC ↗

908 Devices Executives and Management Board

16 members · avg. age 59 · 19 % women

KK

Dr. Kevin Knopp (52)

President, Chief Executive Officer, Co-Founder, Director · since 2012

1.99 M USD

Management

JG

Mr. Joseph Griffith (50)

Chief Financial Officer, Treasurer

1.24 M USD
MT

Mr. Michael Turner (58)

Chief Legal and Administrative Officer, Company Secretary

1.17 M USD
JK

Mr. John Kenneweg (52)

Vice President - Government · since 2019

1.03 M USD
BR

Ms. Barbara Russo (62)

Vice President - Marketing and Corporate Communications

DO

Mr. Don Osmer (60)

Vice President - Human Resources

JF

Mr. Jon Frattaroli (57)

Vice President - Strategy

Board of Directors

CB

Dr. Christopher Brown (50)

Co-Founder, Director · since 2012

1.20 M USD
EH

Mr. E. Kevin Hrusovsky (63)

Independent Chairman of the Board

222,504.00 USD
ML

Ms. Michele Leonhart (69)

Independent Director

220,667.00 USD
KC

Mr. Keith Crandell (64)

Independent Director

202,504.00 USD
MS

Mr. Mark Spoto (56)

Independent Director

200,004.00 USD
FE

Mr. Fenel Eloi (67)

Independent Director

195,004.00 USD

908 Devices Supply Chain

908 Devices Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
15 companies
#NameTrend
1
Novartis
Customer·Pharmaceuticals·CH
0.85
0.77
-0.56
-0.66
0.07
2
Bio-Techne
Supplier·Customer·Life Sciences Tools & Services·US
0.60
0.80
0.79
0.86
0.79
3
Pfizer
Customer·Pharmaceuticals·US
0.44
0.66
0.22
0.07
-0.75
4
WuXi AppTec Co H
Customer·CN
0.30
0.80
0.57
0.75
0.83
5
Transcenta Holding
Supplier·Customer·Biotechnology·CN
0.24
0.76
0.07
0.13

Frequently asked questions about 908 Devices

The business model of 908 Devices Inc. focuses on developing and providing innovative analytical devices for chemical and biomolecular analysis. The company specializes in creating handheld and desktop mass spectrometry instruments that enable real-time, on-site analysis. These devices are designed to deliver accurate and reliable results in various applications such as safety and security, life sciences, and research. 908 Devices Inc. aims to empower scientists, researchers, and field workers with efficient and flexible tools for qualitative and quantitative analysis, ensuring faster decision-making processes and improved productivity in their respective industries.

908 Devices Inc. is primarily active in the industries of chemical, life sciences, and safety and security.

The main competitors of 908 Devices Inc. in the market include companies such as Agilent Technologies, PerkinElmer, Thermo Fisher Scientific, Waters Corporation, and Bruker Corporation.

908 Devices Inc. is a leading provider of mass spectrometry solutions. Founded in 2012, the company is based in Boston, Massachusetts. With a strong focus on delivering innovative chemical analysis tools, 908 Devices Inc. has developed cutting-edge technologies that enable reliable and fast chemical analysis both in the lab and in the field. Their portable and handheld devices are widely used for applications including safety and security, life sciences, and first responder efforts. With a commitment to pushing the boundaries of analytical capabilities, 908 Devices Inc. continues to revolutionize the field of mass spectrometry through their advanced and user-friendly solutions.

Some significant milestones achieved by 908 Devices Inc. include the successful development and launch of their flagship product, the M908™ handheld mass spectrometer, which revolutionized chemical analysis in the field; their collaboration with federal and local law enforcement agencies to enhance security and threat detection capabilities; and their expansion into new markets and industries, such as forensics, environmental analysis, and safety and security. The company has also received numerous awards and recognition for their innovative technologies and contributions to the scientific community.

908 Devices Inc. is primarily present in the United States and Canada.

908 Devices Inc. represents a commitment to advancing science and public safety through innovative technologies. The company focuses on developing and commercializing purpose-built devices for chemical analysis, enabling first responders and scientists to make informed decisions quickly and accurately. 908 Devices Inc. values collaboration, driven by a passion for addressing real-world challenges in research, life sciences, and safety and security industries. With a customer-centric approach, the company strives to deliver solutions that empower users with actionable insights. The corporate philosophy of 908 Devices Inc. revolves around pushing the boundaries of science and using technology to enhance the well-being of society.

Analysts currently set an average price target of 10.20 USD for the 908 Devices stock (median: 10.20 USD), implying +14.9 % versus the latest price. The consensus is based on 10 analyst ratings.

10 analysts currently rate the 908 Devices stock: 9 recommend buying, 1 holding and 0 selling. For 2026, analysts expect 908 Devices to generate revenue of 68.53 M USD and earnings per share of -0.37 USD.

Converted at the current exchange rate, the 908 Devices share trades at 7.69 EUR (8.88 USD).

The 908 Devices share (MASS) is listed on 1 stock exchanges, including: NASDAQ (MASS).

The company 908 Devices Inc. specializes in manufacturing portable devices for chemical analysis. They offer a range of products, including the Momentum product line which includes portable mass spectrometers and gas chromatographs. They also provide the ZipChip system for protein analysis. 908 Devices focuses on specific industries such as life sciences, chemistry, security and defense, and energy. Their devices offer improved mobility, flexibility, and efficiency compared to traditional analysis methods. Their customers include pharmaceutical and biotech companies, research institutions, and regulatory authorities. 908 Devices' unique business model is based on portable devices and advanced technologies tailored to specific industry needs.

The expected revenue of 908 Devices is 68.53 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of 908 Devices is -14.48 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of 908 Devices is currently -23.87. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the 908 Devices stock.

The price-to-sales ratio (P/S) of 908 Devices is currently 5.04. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the 908 Devices stock.

The Eulerpool Quality Score for 908 Devices is 3/10.

The ISIN of 908 Devices is US65443P1021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of 908 Devices is A2QK1S. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of 908 Devices is MASS. The ticker symbol is used to trade 908 Devices shares on the stock exchange.

908 Devices paid dividends every year for the past 0 years.

908 Devices is assigned to the 'Information technology' sector.

The dividends of 908 Devices are distributed in USD.

All fundamentals and in-depth analysis of 908 Devices

Our stock analysis for 908 Devices stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of 908 Devices. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.